Literature DB >> 29873158

Maximizing benefits and mitigating risks with mineralocorticoid receptor antagonist therapy.

Lauren B Cooper1,2, Adrian F Hernandez2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29873158     DOI： 10.1002/ejhf.1221

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  1 in total

1.  Appropriateness rating for the application of optimal medical therapy and multidisciplinary care among heart failure patients.

Authors:  Satoshi Shoji; Shun Kohsaka; Yasuyuki Shiraishi; Shogo Oishi; Mahoto Kato; Shigehito Shiota; Yasuko Takada; Atsushi Mizuno; Dai Yumino; Hiroyuki Yokoyama; Noboru Watanabe; Mitsuaki Isobe
Journal:  ESC Heart Fail       Date:  2020-11-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.